production
Skip to Content

BT5509: BIOLOGIC DRUG DISCOVERY (2021-2022)

Last modified: 16 Aug 2021 13:44


Course Overview

Biologic therapies represent one of the most important and novel areas of drug discovery in the 21st century. The aim of this course is to provide an insight into the success of protein, peptide or antibody based biologic therapies and to examine how this exciting new area will develop over the next decade.

Course Details

Study Type Postgraduate Level 5
Session Second Sub Session Credit Points 15 credits (7.5 ECTS credits)
Campus Aberdeen Sustained Study No
Co-ordinators
  • Dr Frank Ward

What courses & programmes must have been taken before this course?

  • Any Postgraduate Programme

What other courses must be taken with this course?

None.

What courses cannot be taken with this course?

None.

Are there a limited number of places available?

No

Course Description

Large protein or peptide based therapeutics, or biologics have an increasing influence on our ability to treat a range of complex disorders ranging from rare autoimmune diseases, through allergy and even difficult to treat cancers. This is an exciting, rapidly expanding area with several novel therapies being introduced each year. In most cases, the introduction of a novel biologic will offer new potential for treating a particular disease. Development of a biologic is difficult, but the rewards if successful are huge, with sales far in excess of $1billion per annum.

Biologics are different from small molecule drug options because typically they are designed with strong prior knowledge based around how they may alter the disease outcome. The course will address the challenges that specifically face developing biologic therapies including issues around clinical trial design, patient safety and legal issues with regard to developing biosimilar products.

We will use real clinical examples to examine a range of different types of biologic encompassing functional proteins, antibodies and peptides. There will be a strong focus on novel therapeutics that are currently close to market.


In light of Covid-19 this information is indicative and may be subject to change.

Contact Teaching Time

Information on contact teaching time is available from the course guide.

Teaching Breakdown

  • 2 Tutorials during University weeks 26, 31
  • 1 Tutorial during University weeks 27 - 30, 32

More Information about Week Numbers


In light of Covid-19 and the move to blended learning delivery the assessment information advertised for second half-session courses may be subject to change. All updates for second-half session courses will be actioned in advance of the second half-session teaching starting. Please check back regularly for updates.

Summative Assessments

Oral Presentation: Group

Assessment Type Summative Weighting 30
Assessment Weeks Feedback Weeks

Look up Week Numbers

Feedback
Learning Outcomes
Knowledge LevelThinking SkillOutcome
Sorry, we don't have this information available just now. Please check the course guide on MyAberdeen or with the Course Coordinator

Busines flyer assignment

Assessment Type Summative Weighting 30
Assessment Weeks Feedback Weeks

Look up Week Numbers

Feedback
Learning Outcomes
Knowledge LevelThinking SkillOutcome
Sorry, we don't have this information available just now. Please check the course guide on MyAberdeen or with the Course Coordinator

Essay

Assessment Type Summative Weighting 40
Assessment Weeks Feedback Weeks

Look up Week Numbers

Feedback Word Count
Learning Outcomes
Knowledge LevelThinking SkillOutcome
Sorry, we don't have this information available just now. Please check the course guide on MyAberdeen or with the Course Coordinator

Formative Assessment

There are no assessments for this course.

Course Learning Outcomes

Knowledge LevelThinking SkillOutcome
FactualRememberILO’s for this course are available in the course guide.

Compatibility Mode

We have detected that you are have compatibility mode enabled or are using an old version of Internet Explorer. You either need to switch off compatibility mode for this site or upgrade your browser.